Topas Therapeutics is a Hamburg- clinical-stage biotechnology company pioneering a novel approach to treat autoimmune and immune-mediated diseases. Our proprietary Topas Platform leverages antigen-coupled nanoparticles to target liver sinusoidal endothelial cells, inducing a tolerogenic immune re
mehr erfahren